Becker's Oncology

The American Society of Clinical Oncology and will honor eight leaders at the organization’s 2026 annual meeting in May.  Award recipients include researchers, educators and patient advocates, according to a Jan. 20 news release from ASCO. The award recipients are:…

Duarte, Calif.-based City of Hope has named Vanessa Almendro Navarro, PhD, as chief commercialization officer.  Dr. Almendro Navarro will focus on setting the cancer center’s strategic direction for the commercialization of its intellectual property, data and research results, according to…

Oklahoma City-based OU Health has become the first health system in Oklahoma to offer fertility preservation for prepubescent boys before cancer treatment.  Through testicular tissue cryopreservation, immature tissue can be stored and transported to the University of Pittsburgh for preservation.…

University of Chicago Medicine Comprehensive Cancer Center has received a grant from the Ralph Lauren Corporate Foundation to establish the UChicago Medicine Ralph Lauren Center. The UChicago Medicine Ralph Lauren Center will serve patients at Harvey, Ill.-based Ingalls Memorial Hospital…

The FDA issued draft guidance Jan. 21 proposing the use of minimal residual disease and complete response as primary endpoints to support accelerated approval of drugs for multiple myeloma. The draft guidance outlines recommendations for trial design, statistical methods and…

New York City-based Memorial Sloan Kettering Cancer Center has tapped Whitney Snider, MD, as managing partner of the cancer center’s investment pool, MSK Ventures.  MSK Ventures aims to “accelerate investment in and development of breakthrough oncology innovations and inventions,” according…

Use of GLP-1 medications was associated with lower long-term mortality among patients with colorectal cancer and obesity, according to research presented at an oncology conference. Over a 10-year period, GLP-1 drugs were associated with about 5.6 fewer deaths per 100…

The FDA has granted 510(k) clearance to Brain Mets, an AI-based software platform designed to aid in the detection, tracking and treatment planning of brain metastases. The tool, developed by Neosoma, automates lesion identification, volumetric measurement and radiation therapy contouring…

More than half of head and neck cancer clinical trials ended due to either sponsor-driven strategic decisions or poor recruitment, according to a study published Jan. 2 in JAMA Otolaryngology Head & Neck Surgery. Researchers from Miami-based Sylvester Comprehensive Cancer…

Changing diet while undergoing cancer treatment is incredibly challenging. That’s why Jefferson Health, based in Philadelphia, is testing whether large language models such as ChatGPT can help cancer patients receive more tailored nutrition guidance. “It’s difficult to advise patients on…